Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors

Clinical trial NCT00003125 · COMPLETED

Trial details

NCT number: NCT00003125
Sponsor: Georgetown University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Esophageal Cancer Gastric Cancer Lung Cancer Pancreatic Cancer Unspecified Adult Solid Tumor, Protocol Specific

Start date: 1998-01-01
Primary completion: 2004-11-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.